Type 1-polarized DC immunotherapeutic contains heterogeneous populations with IL-12p70 production restricted to a rare subset
Year: 2026
Type: article
Abstract: Monocyte-derived DC therapies programmed for robust IL-12p70 production have been associated with favorable outcomes in cancer clinical trials. However, clinical responses remain inconsistent even under standardized protocols, and the cellular basis for this variability is unknown. We leveraged single-cell multiomics to characterize two widely used DC platforms, the high-IL-12p70-producing α-Type-1-polarized DC (αDC1) and the IL-12p70-deficient DC induced in the presence of PGE 2 (PGE2-DC), at baseline and following rhCD40L activation. DC generated from 7 healthy participants representing the spectrum of rhCD40L-induced IL-12p70 production were profiled by transcriptome analysis with 42-plex surface proteomics, multiplex ELISA, and ELISpot quantification of IL-12p70-producing cells. While αDC1 and PGE2-DC distinctly responded to rhCD40L, αDC1 alone comprised 3 transcriptionally and phenotypically distinct subpopulations in resting and stimulated states. Only a limited fraction of αDC1 coexpressed IL12A and IL12B (IL-12p70 producers), confirmed by ELISpot at the protein level. The distribution of αDC1 subclusters varied markedly between individuals and correlated with bulk cytokine and chemokine secretion profiles. Magnetic enrichment on the surface marker CD116 yielded αDC1 fractions that differentially primed naïve CD4 + T cells, demonstrating these subpopulations are functionally divergent and separable. This heterogeneity may underlie inconsistent clinical outcomes, providing a rationale for subcluster-based release criteria and patient stratification.
Source: JCI Insight
Institution: University of Pittsburgh
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,100
Awards: G1229932737, Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure, G2954584003, G422565255, High-Throughput Computing for Genomics and Bioinformatics Research, G7862446015, Illumina NovaSeq 6000 High Throughput DNA Sequencer for Emory University, Chemical Biology of HIV-1 Nef, University of Pittsburgh MACS/WIHS CCS, Antigen-specific ‘kick and kill’ of the latent HIV reservoir using dendritic cells, Rustbelt Center for AIDS Research (Case/UHC-Pitt CFAR), Emory National Primate Research Center
OpenAlex ID: W7160321690
